Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.
This is the protocol for a review and there is no abstract. The objectives are as follows: To determine whether different doses of prophylactic platelet transfusions (platelet transfusions given to prevent bleeding) affect their efficacy and safety in preventing bleeding in patients with haematological disorders after chemotherapy with or without stem cell transplantation.
Haematology/Transfusion Medicine, NHS Blood and Transplant, Oxford, UK.
Lise J
LJ
Estcourt
Haematology/Transfusion Medicine, NHS Blood and Transplant, Oxford, UK.
Simon
S
Stanworth
Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK.
Carolyn
C
Doree
Cochrane Editorial Unit, The Cochrane Collaboration, Oxford, UK.
Marialena
M
Trivella
Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
Sally
S
Hopewell
NHS Blood and Transplant, John Radcliffe Hospital, Oxford, UK.
Michael F
MF
Murphy
Medicine (hematology) and Pathology Centre for Transfusion Research, The Ottawa Health Research Institute and the University of Ottawa, Ottawa, Canada.
Alan
A
Tinmouth